Jonathan Berr

Jonathan Berr

Jonathan Berr has been a professional journalist since 1991. He has covered a wide variety of beats, ranging from to electric utilities to media conglomerates to tech companies.

While a reporter at Bloomberg News in 2002, he won the Gerald Loeb Award, one of the most prestigious awards in business journalism. He was part of a team at AOL’s DailyFinance that won the New York Press Club’s award for Internet feature writing in 2010. His freelance writing has appeared in Atlantic.com, AOL, Yahoo, MSN and 24/7 Wall Street, along with The New York Times and Business Week.

He lives in New Jersey with his wife and son.

You can reach him at jdberr@gmail.com. Follow him on Twitter at @jdberr.

Recent Articles

Add Cronos Stock to the List of Canadian Pot Stocks to Avoid

Cronos stock started out pretty hot, but recent developments (or the lack thereof) make it a pot stock you want to avoid.

Square Stock Haters Are Wrong Once Again

The haters got it wrong with the SQ stock IPO. Now, they're getting it wrong again. Square is going to move higher in the long run.

Even Near High, Wall Street is Underestimating Microsoft Stock Yet Again

The time is right to buy MSFT stock because Wall Street analysts will eventually see that they have underestimated the company yet again.

Why I Changed My Mind About Canopy Growth Stock

Canopy Growth stock is one of the four big Canadian pot companies that will report results for the quarter ended Sept. 30 this week and Street expectations aren't optimistic.

My Misgivings About Aurora Cannabis Stock Continue to Grow

A year after legalization, things aren't looking good for ACB stock. I recommend waiting on the sidelines until vaping risks clear up.

Amazon Stock Is Worth Buying On a Pullback

The selloff in AMZN stock is an overreaction. But Amazon isn't worth buying yet. This is why you should wait to buy it.

AMD Stock Still Looks Expensive

AMD stock earnings were not eye-popping, but the current valuation on the stock will be for some investors.

Amid A Pot Stock Boom, I Have Misgivings About Aurora Cannabis Stock

I have concerns about Aurora Cannabis stock. For investors eager to cash-in on the pot stock craze, there are better choices than ACB stock.

My Interest in Canopy Growth Stock Goes Beyond Its Price

As a person with Parkinson's Disease, I am rooting for Canopy Growth to succeed, despite my misgivings about CGC stock price.

Comcast Stock Still Has Got More Room To Run Heading Into Summer

Growth in Comcast's Broadband business shows no signs of slowing. Other businesses, including NBCUniversal, are solid performers that should keep CMCSA stock heading higher.